Ursprung des Netzwerks ersten Grades von Chris Horvath
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
23
| Public Company | Pharmaceuticals: Major | 23 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Chris Horvath
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| JUNIPER PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Investor Relations Contact | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
POINT Biopharma, Inc. (United States)
 POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Miscellaneous Commercial Services | Chairman Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Operating Officer Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
POINT Biopharma Corp.
 POINT Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma Corp. is a Canadian company that develops next-generation radiopharmaceuticals for the treatment of cancer. The company is based in Toronto, Canada. POINT Biopharma develops radioligands, which are microscopic, cancer-seeking missiles used to diagnose and treat cancers such as non-Hodgkin's lymphoma and neuroendocrine tumors (NETs). To learn more about the company, interested parties can register online at https\://hub.pointbiopharma.com/investor-day-june-2023. The company was founded by Joe McCann. Joe McCann has been the CEO since incorporation. | Miscellaneous Commercial Services | Chairman Director/Board Member Chief Tech/Sci/R&D Officer Founder | |
| DICE THER | Biotechnology | President Director/Board Member Director/Board Member Corporate Secretary | |
| University of Toronto | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree | |
| McMaster University | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
| SIGILON THERAPEUTICS, INC. | Biotechnology | President Director/Board Member Corporate Secretary | |
| Yale School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Verity Pharmaceuticals, Inc.
 Verity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verity Pharmaceuticals, Inc. operates as a pharmaceutical company. It provides therapeutically relevant agents to the Canadian healthcare community. The company was founded in 2016 and is headquartered in Mississauga, ON. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director of Finance/CFO | |
| ARMO BIOSCIENCES INC | Pharmaceuticals: Major | Chief Executive Officer | |
| Lund University School of Economics & Management | College/University | Undergraduate Degree | |
| AKOUOS | Biotechnology | President | |
| University of Illinois | College/University | Undergraduate Degree | |
Eli Lilly Italia SpA
 Eli Lilly Italia SpA Pharmaceuticals: MajorHealth Technology Eli Lilly Italia SpA manufactures pharmaceutical products. The company was founded by Colonel Eli Lilly in 1876 and is headquartered in Sesto Fiorentino, Italy. | Pharmaceuticals: Major | Chief Executive Officer | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
| Boston University | College/University | Graduate Degree | |
| Chicago Medical School | College/University | Doctorate Degree | |
| DERMIRA, INC. | Pharmaceuticals: Major | Director/Board Member | |
The American Chamber of Commerce in Japan
 The American Chamber of Commerce in Japan Miscellaneous Commercial ServicesCommercial Services The American Chamber of Commerce in Japan is a Chamber of Commerce. The non-profit company is based in Minato-ku, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
| Albert Einstein College of Medicine, Inc. | College/University | Corporate Officer/Principal | |
| Suffolk University Law School | College/University | Graduate Degree | |
| Tufts University School of Medicine | College/University | Doctorate Degree | |
| Worcester Polytechnic Institute | College/University | Undergraduate Degree | |
| OCATA THERAPEUTICS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree | |
Canadian Urologic Oncology Group
 Canadian Urologic Oncology Group BiotechnologyHealth Technology Canadian Urologic Oncology Group operates as a clinical research investigator network. The company is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member | |
| Princess Margaret Hospital | Corporate Officer/Principal | ||
University Health Network
 University Health Network Hospital/Nursing ManagementHealth Services University Health Network operates as a healthcare and medical research organization that provides patient care, education, and research services. Its programs include arthritis program, joint department of medical imaging, Krembil neuroscience center, laboratory medicine program, medical and community care, multi-organ transplant, Peter Munk cardiac center, Princess Margaret cancer, surgery and critical care program, and Toronto rehab. The company was founded in 1986 and is headquartered in Toronto, Canada. | Hospital/Nursing Management | Corporate Officer/Principal | |
Synergex Corp.
 Synergex Corp. Air Freight/CouriersTransportation Synergex Corp. provides supply chain management services in Latin America. It specializes in logistics services, distribution, licensing, sales, localization, packaging and marketing of digital entertainment products. The company was founded in 1986 and is headquartered in Mississauga, Canada. | Air Freight/Couriers | Director/Board Member | |
Verseau Therapeutics, Inc.
 Verseau Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Verseau Therapeutics, Inc. provides immuno-therapy services. The company was founded by Daniel Anderson, Robert Langer, Igor Feldman, and Tatiana Novobrantseva in 2017 and is headquartered in Bedford, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| KURA ONCOLOGY, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Toronto Innovation Acceleration Partners
 Toronto Innovation Acceleration Partners BiotechnologyHealth Technology Toronto Innovation operates as a commercialization agent. Its technologies disclosed span therapeutics, medical devices and diagnostic imaging, information and communications technologies, and advanced manufacturing and clean technologies. The company was founded by Raphael Hofstein in June 2009 and is headquartered in Toronto, Canada. | Biotechnology | Corporate Officer/Principal | |
| Wilfrid Laurier University | College/University | Undergraduate Degree | |
AgMedica Bioscience, Inc.
 AgMedica Bioscience, Inc. Agricultural Commodities/MillingProcess Industries Part of Atlas Global Brands, Inc., AgMedica Bioscience, Inc. is a Canadian company that cultivates, produces, distributes, and sells cannabis-related products. The company is based in Chatham-Kent, Canada. AgMedica Bioscience was acquired by Silver Phoenix Resources, Inc. on January 04, 2023 for $9.32 million. The company was founded by Peter van Mol. Trevor Henry has been the CEO of the company since 2016. | Agricultural Commodities/Milling | Director of Finance/CFO | |
Centre For Probe Development & Commercialization
 Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Puerto Rico School of Medicine | College/University | Undergraduate Degree | |
| GLYCOMIMETICS, INC. | Pharmaceuticals: Major | General Counsel |
Statistik
International
| Vereinigte Staaten | 23 |
| Kanada | 14 |
| Marokko | 2 |
| Vereinigtes Königreich | 2 |
| Irland | 2 |
Sektoral
| Health Technology | 18 |
| Consumer Services | 17 |
| Commercial Services | 6 |
| Communications | 2 |
| Health Services | 2 |
Operativ
| Director/Board Member | 74 |
| Corporate Officer/Principal | 31 |
| Independent Dir/Board Member | 21 |
| Chief Tech/Sci/R&D Officer | 18 |
| Chairman | 17 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jonathan Goodman | 25 |
| Bridget Martell | 19 |
| David Lubner | 19 |
| Yael Margolin | 16 |
| Allan Silber | 15 |
| Philip Johnson | 13 |
| Rajesh K. Malik | 10 |
| Neil Fleshner | 10 |
| Daniel Pearlstein | 8 |
| Matthew Vincent | 7 |
| Myra Rosario Herrle | 6 |
| Joe McCann | 6 |
| William Demers | 6 |
| Jessica Jensen | 5 |
| Gerald Hogue | 4 |
- Börse
- Insiders
- Chris Horvath
- Unternehmensverbindungen
